Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2016

Stockholders' Equity Note [Abstract]

Schedule of changes in stockholders' equity

The following table reflects the effect on the Company’s equity for the three months ended March 31, 2015(in thousands):

	March 31, 2015
Adjustment to Accumulated other comprehensive loss related to the reallocation (from noncontrolling to controlling interests) of foreign currency translation loss attributable to our noncontrolling interest in Litha	$	(3,904	)
Decrease in noncontrolling interests for buy-out of Litha	(32,732		)
Decrease in additional paid-in capital for buy-out of Litha	(2,972		)
Total cash consideration paid related to buy-out of Litha	$	(39,608	)

The following table displays a reconciliation of our beginning and ending balances in shareholders' equity for the three months ended March 31, 2016 (in thousands):

	Attributable to:
	Endo International plc			Noncontrolling interests			Total Shareholders’ Equity
Shareholders’ equity at January 1, 2016	$	5,968,030		$	(54	)	$	5,967,976
Net loss	(133,869		)	(2		)	(133,871		)
Other comprehensive income	79,847			56			79,903
Compensation related to share-based awards	14,967			—			14,967
Tax withholding for restricted shares	(10,272		)	—			(10,272		)
Exercise of options	1,952			—			1,952
Issuance of ordinary shares related to the employee stock purchase plan	1,434			—			1,434
Other	2,057			—			2,057
Shareholders’ equity at March 31, 2016	$	5,924,146		$	—		$	5,924,146

The following table displays a reconciliation of our beginning and ending balances in shareholders' equity for the three months ended March 31, 2015 (in thousands):

	Attributable to:
	Endo International plc			Noncontrolling interests			Total Shareholders’ Equity
Shareholders’ equity at January 1, 2015	$	2,374,757		$	33,456		$	2,408,213
Net loss	(75,718		)	—			(75,718		)
Other comprehensive loss	(129,229		)	(606		)	(129,835		)
Compensation related to share-based awards	13,837			—			13,837
Tax withholding for restricted shares	(11,930		)	—			(11,930		)
Exercise of options	18,470			—			18,470
Buy-out of noncontrolling interests, net of contributions	(6,876		)	(32,732		)	(39,608		)
Ordinary shares issued in connection with the Auxilium acquisition	1,519,320			—			1,519,320
Fair value of equity component of acquired Auxilium Notes	278,014			—			278,014
Conversion of Auxilium Notes	145,101			—			145,101
Other	13,852			—			13,852
Shareholders’ equity at March 31, 2015	$	4,139,598		$	118		$	4,139,716